We also showed stronger inverse associations with hormone receptor-positive subtypes, and no significant association with receptor-negative subtypes of premenopausal BC, as has also been seen in meta-analyses of cohort and case–control studies combined [6, 19]. This evidence concerns the gene NR4A1 and breast cancer.